Ethosuximide

乙琥胺

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEthosuximide
Drug Alias Name琥珀乙烷etosuximida乙琥珀亚胺EthosuximidumZarontin +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHeadacheSeizuresMigraine Disorders +[5] 
Global Approved IndicationsSeizuresEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1960/11/02
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesParke Davis Pharmaceutical Research Div Warner Lambert Co
Inactive CompaniesResearch Institute Of The Mcgill University Health CentreUniversity Of PittsburghThomas Jefferson University +[4] 
Active IndicationsSeizuresEpilepsy
Inactive IndicationsHeadacheMigraine DisordersComplex Regional Pain Syndromes

Other Information

ATC CodeN03AD01
Related LinksWikipediaDrugBankKEGG